BioSpace News Archive

Principal investigators, laboratories, and proteomics researchers in academia, biopharma and contract research organizations can now benefit from an all-in-one nano-, capillary- and micro-flow liquid chromatography system.

Simulations Plus, Inc. today announced that chief executive officer Shawn O’Connor will be presenting at two upcoming investor conferences: BofA Securities 2021 Tech Solutions for Drug Discovery Conference on Monday, September 20, 2021.

Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that Corey Fishman, Chief Executive Officer, will provide a company overview and business update at the H.C. Wainwright 23rd Annual Virtual Global Investment Conference.

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that is has submitted a Pre-Investigational New Drug application (Pre-IND) to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of Ampligen as a potential infusion therapy for Post-COVID-19 Cognitive Dysfunction (PCCD).

Royal Biologics, an ortho-biologics company focused on Autologous and Live Cellular solutions, has announced FDA 510K approval of their Maxx™-PRP concentration system.

Quantori today announced the appointment of Solman Rahman to Executive Vice President, Europe to support Quantori’s aggressive growth strategy and strengthen its market position as a premier global services provider.

Single dose radiotherapy services have evolved in scope in oncology to meet the needs of new image-guided radiotherapy.

Healthcare organizations around the world have started acquiring services from global healthcare outsourcing market as availing these services can help these organizations control the increasing costs of providing backend and management healthcare services.

The latest Fact.MR research study offers oral antivirals demand outlook and studies growth opportunities in key segments, including type, drug class, disease indication, and distribution channel.

The word ‘3D printing’ is a hypernym for creation of 3D objects with the help of various additional approaches to manufacturing.